To include your compound in the COVID-19 Resource Center, submit it here.

MDV3100: Phase II started

Medivation and Astellas began an open-label, European Phase II trial

Read the full 103 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE